Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1995 4
1996 5
1997 5
1998 1
1999 1
2000 3
2001 2
2002 2
2004 3
2005 2
2006 2
2007 2
2009 2
2010 4
2011 6
2012 5
2013 4
2014 4
2015 6
2016 4
2017 4
2018 5
2019 11
2020 7
2021 9
2022 11
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Machado-Joseph disease type 1"
Page 1
The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.
Koppenol R, Conceição A, Afonso IT, Afonso-Reis R, Costa RG, Tomé S, Teixeira D, da Silva JP, Côdesso JM, Brito DVC, Mendonça L, Marcelo A, Pereira de Almeida L, Matos CA, Nóbrega C. Koppenol R, et al. Brain. 2023 Jun 1;146(6):2346-2363. doi: 10.1093/brain/awac473. Brain. 2023. PMID: 36511898 Free PMC article.
Our work aimed at exploring a putative new therapeutic target for the two forms of SCA with higher worldwide prevalence, SCA type 2 (SCA2) and type 3 (SCA3), which are caused by expanded forms of ataxin-2 (ATXN2) and ataxin-3 (ATXN3), respectively. ...We evaluated t …
Our work aimed at exploring a putative new therapeutic target for the two forms of SCA with higher worldwide prevalence, SCA type 2 ( …
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. Diabetes Care. 2022. PMID: 35061867 Free PMC article. Clinical Trial.
OBJECTIVE: Finerenone significantly improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease trial. ...Patients …
OBJECTIVE: Finerenone significantly improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 dia …
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
COVIDSurg Collaborative, GlobalSurg Collaborative. COVIDSurg Collaborative, GlobalSurg Collaborative. Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101. Br J Surg. 2021. PMID: 33761533 Free PMC article.
METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence a …
METHODS: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were base …
The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies.
Ruano L, Melo C, Silva MC, Coutinho P. Ruano L, et al. Neuroepidemiology. 2014;42(3):174-83. doi: 10.1159/000358801. Epub 2014 Mar 5. Neuroepidemiology. 2014. PMID: 24603320 Free article. Review.
The prevalence range of dominant HCA was 0.0-5.6/10(5), with an average of 2.7/10(5) (1.5-4.0/10(5)). Spinocerebellar ataxia type 3 (SCA3)/Machado-Joseph disease was the most common dominant ataxia, followed by SCA2 and SCA6. ...The prevalence o …
The prevalence range of dominant HCA was 0.0-5.6/10(5), with an average of 2.7/10(5) (1.5-4.0/10(5)). Spinocerebellar ataxia type …
Spinocerebellar ataxias.
Teive HA. Teive HA. Arq Neuropsiquiatr. 2009 Dec;67(4):1133-42. Arq Neuropsiquiatr. 2009. PMID: 20069236 Free article. Review.
RESULTS: Thirty types of SCAs are currently known, and 16 genes associated with the disease have been identified. The most common types are SCA type 3, or Machado-Joseph disease, SCA type 10 and SCA types 7, 2, 1 and 6. ...CONCLUSI …
RESULTS: Thirty types of SCAs are currently known, and 16 genes associated with the disease have been identified. The most common typ …
Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).
Colomer Gould VF. Colomer Gould VF. Neurotherapeutics. 2012 Apr;9(2):285-96. doi: 10.1007/s13311-012-0117-x. Neurotherapeutics. 2012. PMID: 22451301 Free PMC article. Review.
Machado-Joseph disease, also called spinocerebellar ataxia type 3 (MJD/SCA3), is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a pathological polyglutamine stretch (mutant ataxin-3). ...On the basis of striking similariti …
Machado-Joseph disease, also called spinocerebellar ataxia type 3 (MJD/SCA3), is a hereditary and neurodegenerat …
Olfactory Function in SCA10.
Moscovich M, Munhoz RP, Moro A, Raskin S, McFarland K, Ashizawa T, Teive HAG, Silveira-Moriyama L. Moscovich M, et al. Cerebellum. 2019 Feb;18(1):85-90. doi: 10.1007/s12311-018-0954-1. Cerebellum. 2019. PMID: 29922950 Free PMC article.
Olfactory identification was tested in three groups of 30 patients (SCA10, SCA3, and Parkinson's disease (PD)) and 44 healthy controls using the Sniffin' Sticks (SS16) test. Mean SS16 score was 11.9 2.9 for the SCA10 group, 12.3 1.9 for the SCA3 group, 6.6 2.8 for t …
Olfactory identification was tested in three groups of 30 patients (SCA10, SCA3, and Parkinson's disease (PD)) and 44 healthy control …
Association between restless legs syndrome and other movement disorders.
Alonso-Navarro H, García-Martín E, Agúndez JAG, Jiménez-Jiménez FJ. Alonso-Navarro H, et al. Neurology. 2019 May 14;92(20):948-964. doi: 10.1212/WNL.0000000000007500. Epub 2019 Apr 19. Neurology. 2019. PMID: 31004074 Review.
OBJECTIVE: This review focuses on the possible association between restless legs syndrome (RLS) and movement disorders, including Parkinson disease (PD), other parkinsonian syndromes, essential tremor, choreic and dystonic syndromes, Tourette syndrome, and heredodegenerati …
OBJECTIVE: This review focuses on the possible association between restless legs syndrome (RLS) and movement disorders, including Parkinson …
Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Bolzan G, Leotti VB, de Oliveira CM, Ecco G, Cappelli AH, Rocha AG, Kersting N, Rieck M, de Sena LS, Martins AC, Saraiva-Pereira ML, Jardim LB. Bolzan G, et al. Cerebellum. 2022 Apr;21(2):297-305. doi: 10.1007/s12311-021-01299-8. Epub 2021 Jul 6. Cerebellum. 2022. PMID: 34231179
Although health-related quality of life (HRQoL) has been increasingly valued in healthcare and in clinical trials, there is scarce information about it in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD). This study describes the HRQoL r …
Although health-related quality of life (HRQoL) has been increasingly valued in healthcare and in clinical trials, there is scarce informati …
Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
da Silva Carvalho G, Saute JA, Haas CB, Torrez VR, Brochier AW, Souza GN, Furtado GV, Gheno T, Russo A, Monte TL, Schumacher-Schuh A, D'Avila R, Donis KC, Castilhos RM, Souza DO, Saraiva-Pereira ML, Torman VL, Camey S, Portela LV, Jardim LB. da Silva Carvalho G, et al. Cerebellum. 2016 Aug;15(4):518-25. doi: 10.1007/s12311-015-0719-z. Cerebellum. 2016. PMID: 26395908
The aim of the present study is to describe the serum concentrations of a broad spectrum of cytokines in symptomatic and asymptomatic carriers of Machado Joseph disease (SCA3/MJD) CAG expansions. Molecularly confirmed carriers and controls were studied. Age a …
The aim of the present study is to describe the serum concentrations of a broad spectrum of cytokines in symptomatic and asymptomatic carrie …
111 results